ICU Medical Q3 2023 Earnings Report
Key Takeaways
ICU Medical announced third quarter 2023 financial results with revenue of $553.3 million, compared to $597.9 million in the same period last year. GAAP net income was $7.2 million, or $0.30 per diluted share, compared to a GAAP net loss of $(13.2) million, or $(0.55) per diluted share, for the third quarter of 2022. Adjusted diluted earnings per share was $1.57 as compared to $1.75 for the third quarter of 2022.
Third quarter revenue was $553.3 million, compared to $597.9 million in the same period last year.
GAAP gross profit for the third quarter of 2023 was $183.9 million, as compared to $186.4 million in the same period last year.
GAAP gross margin for the third quarter of 2023 was 33%, as compared to 31% in the same period last year.
Adjusted diluted earnings per share for the third quarter of 2023 was $1.57 as compared to $1.75 for the third quarter of 2022.
ICU Medical
ICU Medical
ICU Medical Revenue by Segment
Forward Guidance
No forward guidance was provided in the earnings report.
Revenue & Expenses
Visualization of income flow from segment revenue to net income